Lead Partner: Crown Bioscience
Crown Bioscience is a cutting edge translational technology company providing drug discovery and preclinical development services in the areas of oncology, immunology, inflammation, cardiovascular, and metabolic disease. We bring clarity to drug discovery and enable clients around the world to deliver superior clinical candidates. Our premier translational platforms for cancer, inflammation, and metabolic disease help our clients accelerate their new drug development programs.
Programme Partner: Genoway
For the past 20 years, genOway has aimed to improve the predictability and reliability of preclinical data by designing models of high physiological relevancy to best meet researchers’ needs. With a catalog of humanized immune checkpoint mouse models, and mice featuring the human immune system, genOway possesses a broad set of tools to help decipher the mechanism of action as well as the efficacy and safety of drugs targeting the immune system. Additionally, genOway owns strong intellectual property rights, combining patents and licensing agreements, enabling the company to provide end users the necessary freedom to operate.
Spotlight Partner: Covance
Preclinical oncology solutions business of Covance. Access a comprehensive range of in vitro and in vivo preclinical oncology pharmacology services now available within Covance. You can progress your oncology therapeutic through all phases of research and development with Covance’s end-to-end solutions.
Spotlight Partner: Reaction Biology Europe
Reaction Biology Europe is a leading contract research organization for discovery of conventional and immune-modulating drugs in oncology. As an innovation driver in the area of immuno- oncology, we will introduce SubQPerior, an implantation method to overcome common issues such as heterogeneity and ulceration in subcutaneous tumor models. We have partnered with Reaction Biology, an early-stage drug discovery CRO, to provide our customers with a full suite of services for targeted and phenotypic drug discovery approaches. Let’s discover together.
Spotlight Partner: Allcyte
Allcyte is a pioneer in the field of functional precision oncology. We provide actionable data on the activity of drug candidates directly in live tissue samples of human cancer patients to support strategic R&D decision making. Allcyte can do this with unprecedented single cell resolution, demonstrated clinical translatability and scale by leveraging our Pharmacoscopy® high content imaging platform. Our goal is to increase the success rate of clinical trials by enhancing the patient relevance of translational research.
Spotlight Partner: BioReperia AB
BioReperia is a privately owned contract research organization (CRO) that was founded in 2015 based on technology developed at Linköping University in Sweden. Our technology is used to accelerate drug discovery and in clinical trials to test individual treatments on specific patients. We are active as a CRO in the European market for drug discovery in academic institutions and in pharmaceutical companies. BioReperia is currently involved in several EU-funded projects and always looking for additional ways that we can impact research in healthcare, academia, and the pharmaceutical industry. We welcome collaborations that can speed up development of cutting-edge technology for drug discovery.
Workshop Partner: Overwatch
Overwatch is software that makes preclinical research more reproducible. Design complex studies in minutes, invite your team and automate the most repetitive (and error-prone) parts of your workflow so you can focus on what you do best: research. That means no more manual data entry, no more spreadsheets and no more lost notebooks — increasing speed, accuracy and collaboration across your In vivo team. It’s easy to get started, there’s no installation and there’s a free trial: three things everyone loves. Start working faster and more accurately today.
Exhibition Partner: vivoPharm
VIVOPHARM, a CGI company (NASDAQ:CGIX), is a successful and fast-growing precision contract research organisation (CRO) providing integrated preclinical services from bench to bedside worldwide. We use our experience and expertise to assist in the planning of and conducting tailored studies, from discovery stages through to clinical.
Exhibition Partner: ECTICA TECHNOLOGIES AG
Ectica Technologies has developed a superior hydrogel Plate, the 3DProSeed® Hydrogel Plate, that enables the establishment of a stromal environment starting from a fully synthetic hydrogel pre-casted in microtiter plate delivered to the user hydrated, ready for cell seeding. Stromal, tumour and immune cells can be added subsequently to establish 3D co-culture systems to address complex questions in cancer biology. Ectica Technologies supplies the 3DProSeed product directly to the customer, with possibility to customize it in terms of chemistry, format and branding. Patient-derived tumour cells with their associated stromal cells can be offered together with the product. Ectica Technologies can support the assay-development phase and subsequently transfer the technology to the customer for routine activities or directly supply the products for assay development.
Exhibition Partner: GemPharmatech
GemPharmatech Co., Ltd. is a leading company in China to provide high-quality resources and services for biomedical community as well as pharmaceutical companies. Based on more than 16 years’ practice in laboratory animals of the former entity, GemPharmatech has the vision and is striving to become the best one-stop service center for production, distribution, and phenotyping of gene-modified mouse models for partners all across the world.